Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues

Annals of Nutrition and Metabolism

Volumn 52, Issue 1, 2008, Pages 58-67

  Luci, Sebastian ^a   Hirche, Frank ^a   Eder, Klaus ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Caloric restriction; Carnitine; Fasting; Novel organic cation transporter 2; Peroxisome proliferator activated receptor

Indexed keywords

ACYL COENZYME A OXIDASE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; MESSENGER RNA; ORGANIC CATION TRANSPORTER 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIC RESTRICTION; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FEMALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; WEIGHT CHANGE;

ANIMALS; CALORIC RESTRICTION; CARNITINE; FASTING; FEMALE; KIDNEY; LIVER; MYOCARDIUM; ORGANIC CATION TRANSPORT PROTEINS; PPAR ALPHA; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

RATTUS;

EID: 42149152634     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118872     Document Type: Article

References (49)

1. McGarry JD, Brown NF: The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997;244:1-14.
2. Brass EP: Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol Rev 2002;54:589-598.
3. Steiber A, Kerner J, Hoppel CL: Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Asp Med 2004;25:455-473.
4. Lohninger A, Pittner G, Pittner F: L-carnitine: new aspects of a known compound - a brief survey. Chem Mon 2005;136:1255-1266.
5. Rebouche CJ, Seim H: Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 1998;18:39-61.
6. Vaz FM, Wanders RJ: Carnitine biosynthesis in mammals. Biochem J 361:417-429.
7. van Vlies N, Wanders RJ, Vaz FM: Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: differences between the mouse and the rat. Anal Biochem 2006;354:132-139.
8. Lahjouji K, Mitchell GA, Qureshi IA: Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab 2001;73:287-297.
9. Tein I: Carnitine transport: pathophysiology and metabolism of known defects. J Inherit Metab Dis 2003;26:147-169.
10. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A: Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997;419:107-111.
11. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A: Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998;273:20378-20382.
12. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A: Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 2000;275:40064-40072.
13. + -dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999;291:778-784.
14. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A: Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 2001;59:358-366.
15. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V: Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999;290:1482-1492.
16. Slitt AL, Cherrington NJ, Hartley DP, Leazer MT, Klaassen CD: Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 2002;30:212-219.
17. Luci S, Geissler S, König B, Koch A, Stangl GI, Hirche F, Eder K: PPARα agonists upregulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 2006;24:704-708.
18. Chao P-M, Chao C-Y, Lin F-J, Huang C-J: Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4A1 genes in rats and activates PPARα. J Nutr 2001;131:3166-3174.
19. Chao P-M, Hsu SC, Lin F-J, Li YJ, Huang C-J: The up-regulation of hepatic acyl-CoA oxidase and cytochrome P450 4A1 mRNA expression by dietary oxidized frying oil is comparable between male and female rats. Lipids 2004;39:233-238.
20. Sülzle A, Hirche F, Eder K: Thermally oxidized dietary fat upregulates the expression of target genes of PPAR alpha in rat liver. J Nutr 2004;134:1375-1383.
21. Koch A, König B, Luci S, Stangl GI, Eder K: Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats. Br J Nutr 2007;98:882-889.
22. McGarry JD, Robles-Valdes C, Foster DW: Role of carnitine in hepatic ketogenesis. Proc Natl Acad Sci USA 1975;72:4385-4388.
23. Brass EP, Hoppel CL: Carnitine metabolism in the fasting rat. J Biol Chem 1978;253:2688-2693.
24. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 1999;103:1489-1498.
25. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS: Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000;275:28918-28928.
26. Brandt JM, Djouadi F, Kelly D: Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 1998;273:23786-23792.
27. Taylor PM: Absorbing competition for carnitine. J Physiol 2001;532:283.
28. Mascaró C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D: Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 1998;273:8560-8563.
29. Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S: The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 1992;11:433-439.
30. Mandard S, Müller M, Kersten S: Peroxisome proliferator receptor α target genes. Cell Mol Life Sci 2004;61:393-416.
31. National Research Council: Nutrient Requirements of Laboratory Animals, ed 4, rev. Washington, National Academy Press, 1995.
32. Vernez L, Wenk M, Krähenbühl S: Determination of carnitine and acylcarnitines in plasma by high-performance liquid chromatography/ electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 2004;18:1233-1238.
33. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
34. Li RY, Zhang QH, Liu Z, Qiao J, Zhao SX, Shao L, Xiao HS, Chen JL, Chen MD, Song HD: Effect of short-term and long-term fasting on transcriptional regulation of metabolic genes in rat tissues. Biochem Biophys Res Commun 2006;344:562-570.
35. van Vlies N, Ferdinandusse S, Turkenburg M, Wanders RJ, Vaz FM: PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim Biophys Acta 2007;1767:1134-1142.
36. Koch A, König B, Stangl GI, Eder K: PPARα mediates transcriptional up-regulation of novel organic cation transporters (OCTN)-2 and -3 and enzymes involved in hepatic carnitine synthesis. Exp Biol Med, in press.
37. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B: Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001;142:4195-4202.
38. Shimakura J, Terada T, Saito H, Katsura T, Inui K: Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha. Am J Physiol Gastrointest Liver Physiol 2006;291:G851-G856.
39. Frohlich J, Seccombe DW, Hahn P, Dodek P, Hynie I: Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate. Metabolism 1978;27:555-561.
40. Hokland BM, Bremer J: Metabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney. Biochim Biophys Acta 1986;886:223-230.
41. Zamora S, Benador N, Lacourt G, Girardin E: Renal handling of carnitine in ill preterm and term neonates. J Pediatr 1995;127:975-978.
42. Zammit VA, Price NT, Jackson VN, Park B-S: The role of carnitine acyltransferases in the maintenance of cell function. Chem Mon 2005;136:1299-1309.
43. Kato Y, Sugiura M, Sugiura T, Wakayama T, Kubo Y, Kobayashi D, Sai Y, Tamai I, Iseki S, Tsuji A: Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes. Mol Pharmacol 2006;70:829-837.
44. Rebouche CJ: Effect of dietary carnitine isomers and gamma-butyrobetaine on L-carnitine biosynthesis and metabolism in the rat. J Nutr 1983;113:1906-1913.
45. Paul HS, Adibi SA: Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. J Clin Invest 1979;64:405-412.
46. Koepsell H, Endou H: The SLC22 drug transporter family. Pflugers Arch 447:666-676.
47. Lahjouji K, Elimrani I, Lafond J, Leduc L, Qureshi IA, Mitchell GA: L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. Am J Physiol Cell Physiol 2004;287:C263-C269.
48. Grube M, Meyer zu Schwabedissen HE, Präger D, Haney J, Möritz KU, Meissner K, Rosskopf D, Eckel L, Böhm M, Jedlitschky G, Kroemer HK: Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 2006;113:1114-1122.
49. Hirano T, Yasuda S, Osaka Y, Kobayashi M, Itagaki S, Iseki K: Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Biochim Biophys Acta 2006;1758:1743-1750.